Europe In Vitro Diagnostics Market To Reach $28.10 Billion By 2030

Europe In Vitro Diagnostics Market Growth & Trends

The Europe in vitro diagnostics market size is expected to reach USD 28.10 billion by 2030, registering a CAGR of 0.7% during the forecast period, according to a new report by Grand View Research, Inc. This expected increase in the demand is ascribed to the presence of novel and promising technologies in clinical laboratories, such as the introduction of Troponin T test by Roche Diagnostics in May, 2011.

Persistent research and development efforts made to introduce automation in laboratories that perform analytical testsare projected to propel the market growth over the forecast period. Clinical laboratory operations require automated analyzers to cope with the large test volumes,which enhance the overall operational workflow. It minimizes the need for dedicated operator training andnegates the risk of human errors. In addition, the rising demand for portable and handheld IVD devicesis one of the major factors pushing forward the growth of the market.

The increasing prevalence of chronic diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising geriatric population coupled with the rising awareness towards early diagnosis in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe IVD market.

 Request a free sample copy or view report summary: Europe In Vitro Diagnostics Market Report

Europe In Vitro Diagnostics Market Report Highlights

• In 2022, the reagents segment dominated the Europe IVD market due to its increasing number of applications in the companion diagnostics area and the introduction of disease specific kits, such as the XpertTB kit

• The IVD instruments market is anticipated to show lucrative growth due to the introduction of portable instruments, such as MinION Analyzer by Oxford Nanopore, and the availability of various platforms to performtarget sequence analysis, thereby driving the overall demand

• UK is expected to be the fastest growing regionduring the forecast period.The rising demand for the point-of-care devices coupled with the government interventions to incorporate innovative, cost-effective solutions in the healthcare services are expected to drive the market growth during the forecast period.

• The hospital-based IVD testing segment held the largest share. The highprocedure volumes in this segment, is one of the major reasons resulting inthehigh share and;hence, is anticipated to maintain its market position over the forecast period.

• The presence of major IVD market players in Europe accelerates the penetration of the IVD products throughout the European Union. For instance, in September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring withenhanced flexibility and automation.

Europe In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the Europe in vitro diagnostics market based on product, technology, end-use, application, and region:

Europe In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Reagents

• Services

Europe In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Immunology

• Haematology

• Clinical Chemistry

• Molecular Diagnostics

• Coagulation  

• Microbiology

• Others

Europe In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Diseases

• Diabetes

• Oncology/Cancer

• Cardiology

• Nephrology

• Autoimmune Diseases

• Drug Testing

• Other

Europe In Vitro Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Laboratories

• Home Care

• Others

Europe In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Europe 

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

List of Key Players in the Europe In Vitro Diagnostics Market

• Bio-Rad Laboratories, Inc

• Abbott

• Sysmex Corporation

• BD

• BIOMÉRIEUX

• Danaher

• F. Hoffmann-La Roche Ltd

• Siemens

• QIAGEN

• Thermo Fisher Scientific Inc